Cargando…
RGD-Modified Nano-Liposomes Encapsulated Eptifibatide with Proper Hemocompatibility and Cytotoxicity Effect
BACKGROUND: Eptifibatide (Integrilin®) is a hepta-peptide drug which specifically prevents the aggregation of activated platelets. The peptide drugs are encapsulated into nanolipisomes in order to decreasing their side effects and improving their half-life and bioavailability. OBJECTIVES: In this st...
Autores principales: | Bardania, Hassan, Shojaosadati, Seyed Abbas, Kobarfard, Farzad, Morshedi, Dina, Aliakbari, Farhang, Tahoori, Mohammad Taher, Roshani, Elahe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Institute of Genetic Engineering and Biotechnology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697844/ https://www.ncbi.nlm.nih.gov/pubmed/31457055 http://dx.doi.org/10.21859/ijb.2008 |
Ejemplares similares
-
Optimization and Characterization of Aspirin Encapsulated Nano-liposomes
por: Khodayar, Samira, et al.
Publicado: (2018) -
RP-HPLC Method Development and Validation for Determination of Eptifibatide Acetate in Bulk Drug Substance and Pharmaceutical Dosage Forms
por: Bavand Savadkouhi, Maryam, et al.
Publicado: (2017) -
Using small molecules as a new challenge to redirect metabolic pathway
por: Morshedi, Dina, et al.
Publicado: (2013) -
Temperature-dependent formulation of a hydrogel based on Hyaluronic acid-polydimethylsiloxane for biomedical applications
por: Khaleghi, Maryam, et al.
Publicado: (2020) -
Multiple neuroprotective features of Scutellaria pinnatifida–derived small molecule
por: Parsafar, Soha, et al.
Publicado: (2020)